$TRUP

GALLAGHER JOHN R sold $11K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 431 shares of TRUPANION, INC. (TRUP) at $25.35 on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Jul 1, 2026, 11:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 11:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

Confirms the COO reduced holdings by ~$10.9k; typically not a catalyst for re-rating absent additional fundamental news.

02

Market read

Traders may log the sale for sentiment/positioning, but it is unlikely to drive price without corroborating fundamentals.

03

What to watch

The filing does not indicate intent beyond the plan; without context on prior grants/sales cadence, it’s hard to infer directionality.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-01; sale executed 2026-06-29

Background

SEC Form 4 discloses an officer’s open-market sale executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

TRUP insider filing shows COO John R. Gallagher sold 431 shares at $25.35 on 2026-06-29 under a 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect would be second-order via sentiment rather than fundamentals.

Evidence & confidence

Form 4 is a primary disclosure, but the transaction is explicitly under a pre-arranged 10b5-1 plan and is small relative to typical market moves.

Market effects

No clear sector read-through from a single routine 10b5-1 sale.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may watch for follow-on sales or changes in buying behavior.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction was disclosed on Form 4.

  • GALLAGHER JOHN R

    Chief Operating Officer who sold 431 shares.

  • Rule 10b5-1 plan

    Pre-arranged plan that generally reduces informational content of the sale.

Related articles

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026.htm EX-99.1 Document Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced fin